These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 3549500)
1. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice. Flatt PR; Bailey CJ; Hampton SM; Swanston-Flatt SK; Marks V Horm Metab Res; 1987 Jan; 19(1):1-5. PubMed ID: 3549500 [TBL] [Abstract][Full Text] [Related]
2. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background. Garris DR; Garris BL Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481 [TBL] [Abstract][Full Text] [Related]
3. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice. Flatt PR; Bailey CJ Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589 [TBL] [Abstract][Full Text] [Related]
4. The effect of ponalrestat on sorbitol levels in the lens of obese and diabetic mice. Vicario PP; Slater EE; Saperstein R Biochem Int; 1989 Sep; 19(3):553-61. PubMed ID: 2510726 [TBL] [Abstract][Full Text] [Related]
5. Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB- Lepr (db)) and obese (DBA- Lep (ob)) mice. Chua S; Liu SM; Li Q; Yang L; Thassanapaff VT; Fisher P Diabetologia; 2002 Jul; 45(7):976-90. PubMed ID: 12136396 [TBL] [Abstract][Full Text] [Related]
6. Substance P, neurokinin A, vasoactive intestinal polypeptide and gastrin releasing peptide in the intestine and pancreas of spontaneously obese-diabetic mice. Bailey CJ; Flatt PR; Deacon CF; Shaw C; Conlon JM Regul Pept; 1986 Dec; 16(3-4):339-48. PubMed ID: 2436255 [TBL] [Abstract][Full Text] [Related]
7. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia. Garris DR; Garris BL Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653 [TBL] [Abstract][Full Text] [Related]
8. Immunoreactive neurotensin in spontaneous syndromes of obesity and diabetes in mice. Sheppard MC; Bailey CJ; Flatt PR; Swanston-Flatt SK; Shennan KI Acta Endocrinol (Copenh); 1985 Apr; 108(4):532-6. PubMed ID: 3887830 [TBL] [Abstract][Full Text] [Related]
9. Effects of enzyme induction therapy on glucose and drug metabolism in obese mice model of non-insulin dependent diabetes mellitus. Karvonen I; Stengård JH; Huupponen R; Stenbäck FG; Sotaniemi EA Diabetes Res; 1989 Feb; 10(2):85-92. PubMed ID: 2501061 [TBL] [Abstract][Full Text] [Related]
10. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice. Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H Eur J Pharmacol; 2008 Jul; 588(2-3):325-32. PubMed ID: 18499100 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of glycated insulin in diabetic animals using immunocytochemistry and radioimmunoassay. McKillop AM; Mooney MH; Harriott P; Flatt PR; O'Harte FP Biochem Biophys Res Commun; 2001 Aug; 286(3):524-8. PubMed ID: 11511090 [TBL] [Abstract][Full Text] [Related]
13. Role of adrenal glands in the development of abnormal glucose and insulin homeostasis in genetically obese (ob/ob) mice. Bailey CJ; Day C; Bray GA; Lipson LG; Flatt PR Horm Metab Res; 1986 Jun; 18(6):357-60. PubMed ID: 3525360 [TBL] [Abstract][Full Text] [Related]
14. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice. Green BD; Irwin N; Cassidy RS; Gault VA; Flatt PR Peptides; 2006 Sep; 27(9):2343-9. PubMed ID: 16730098 [TBL] [Abstract][Full Text] [Related]
15. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics. Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196 [TBL] [Abstract][Full Text] [Related]
16. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice. Chen MD; Liou SJ; Lin PY; Yang VC; Alexander PS; Lin WH Biol Trace Elem Res; 1998 Mar; 61(3):303-11. PubMed ID: 9533568 [TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Wang Q; Brubaker PL Diabetologia; 2002 Sep; 45(9):1263-73. PubMed ID: 12242459 [TBL] [Abstract][Full Text] [Related]
18. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025 [TBL] [Abstract][Full Text] [Related]
19. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice. van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560 [TBL] [Abstract][Full Text] [Related]
20. Effect of age on hepatocyte and soleus muscle insulin receptor binding in lean and genetically obese diabetic (ob/ob) mice. Lord JM; Atkins TW Diabetes Res; 1985 Sep; 2(5):259-65. PubMed ID: 3905189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]